Top

European Journal of Nuclear Medicine and Molecular Imaging

Published in:

01-07-2018 | Original Article

The central zone has increased ⁶⁸Ga-PSMA-11 uptake: “Mickey Mouse ears” can be hot on ⁶⁸Ga-PSMA-11 PET

Authors: Daniele A. Pizzuto, Julian Müller, Urs Mühlematter, Niels J. Rupp, Antonia Töpfer, Ashkan Mortezavi, Hannes Nagel, Benedikt Kranzbühler, Daniel Eberli, Irene A. Burger

Published in: European Journal of Nuclear Medicine and Molecular Imaging | Issue 8/2018

Abstract

Purpose

Given the good correlation between PSMA expression and intraglandular tumour aggressiveness based on immunohistochemistry, there is increasing interest in ⁶⁸Ga-PSMA-11 PET/MRI for staging prostate cancer (PCA). Therefore, accurate knowledge of prostate anatomy as well as normal distribution of PSMA within the prostate gland is becoming essential. The aim of this study was to investigate the physiological intraprostatic distribution of ⁶⁸Ga-PSMA-11.

Methods

We retrospectively analysed all patients who underwent a staging ⁶⁸Ga-PSMA-11 PET/MRI scan between June 2016 and January 2018 for high-risk PCA, underwent radical prostatectomy in our institution, and gave written consent for further data analysis. In each patient, standardized volumes of interest (VOIs) were placed bilaterally in the central, transition and peripheral zones within the zonal anatomy according to T2 weighted sequences in the axial and coronal planes. VOIs were only placed if they were safely within healthy tissue without spillover from the PCA. SUV_max and SUV_mean were determined and their differences among the regions were assessed using the Wilcoxon signed-ranks test.

Results

Of 283 consecutive patients scanned with ⁶⁸Ga-PSMA-11 PET/MR, 31 were analysed. A total of 133 VOIs were placed, 46 in the central zone, 41 in the transition zone and 46 in the peripheral zone. Differences in SUV_max between the central zone (mean 3.9 ± 0.58) and transition zone (mean 3.2 ± 0.59) and between the central zone and peripheral zone (mean 2.7 ± 0.54) were statistically significant (both p < 0.001).

Conclusion

Our results suggest that higher ⁶⁸Ga-PSMA-11 accumulation in the central zone than in the transition and peripheral zones is normal, and leads to a pattern resembling “Mickey Mouse ears” on ⁶⁸Ga-PSMA-11 PET. This pattern could be helpful in avoiding false-positive interpretations of PET scans.

Available only for authorised users

Cabarrus MC, Westphalen AC. Multiparametric magnetic resonance imaging of the prostate – a basic tutorial. Transl Androl Urol. 2017;6:376–86. https://doi.org/10.21037/tau.2017.01.06.CrossRefPubMedPubMedCentral

Becker AS, Cornelius A, Reiner CS, Stocker D, Ulbrich EJ, Barth BK, et al. Direct comparison of PI-RADS version 2 and version 1 regarding interreader agreement and diagnostic accuracy for the detection of clinically significant prostate cancer. Eur J Radiol. 2017;94:58–63. https://doi.org/10.1016/j.ejrad.2017.07.016.CrossRefPubMed

Afshar-Oromieh A, Avtzi E, Giesel FL, Holland-Letz T, Linhart HG, Eder M, et al. The diagnostic value of PET/CT imaging with the (68)Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer. Eur J Nucl Med Mol Imaging. 2015;42:197–209. https://doi.org/10.1007/s00259-014-2949-6.CrossRefPubMed

Eiber M, Maurer T, Souvatzoglou M, Beer AJ, Ruffani A, Haller B, et al. Evaluation of hybrid 68Ga-PSMA ligand PET/CT in 248 patients with biochemical recurrence after radical prostatectomy. J Nucl Med. 2015;56:668–74. https://doi.org/10.2967/jnumed.115.154153.CrossRefPubMed

Afshar-Oromieh A, Holland-Letz T, Giesel FL, Kratochwil C, Mier W, Haufe S, et al. Diagnostic performance of (68)Ga-PSMA-11 (HBED-CC) PET/CT in patients with recurrent prostate cancer: evaluation in 1007 patients. Eur J Nucl Med Mol Imaging. 2017;44:1258–68. https://doi.org/10.1007/s00259-017-3711-7.CrossRefPubMedPubMedCentral

Kasperzyk JL, Finn SP, Flavin R, Fiorentino M, Lis R, Hendrickson WK, et al. Prostate-specific membrane antigen protein expression in tumor tissue and risk of lethal prostate cancer. Cancer Epidemiol Biomarkers Prev. 2013;22:2354–63. https://doi.org/10.1158/1055-9965.EPI-13-0668.CrossRefPubMedPubMedCentral

Marchal C, Redondo M, Padilla M, Caballero J, Rodrigo I, Garcia J, et al. Expression of prostate specific membrane antigen (PSMA) in prostatic adenocarcinoma and prostatic intraepithelial neoplasia. Histol Histopathol. 2004;19:715–8. https://doi.org/10.14670/HH-19.715.PubMedCrossRef

Eiber M, Nekolla SG, Maurer T, Weirich G, Wester HJ, Schwaiger M. (68)Ga-PSMA PET/MR with multimodality image analysis for primary prostate cancer. Abdom Imaging. 2015;40:1769–71. https://doi.org/10.1007/s00261-014-0301-z.CrossRefPubMed

Zamboglou C, Drendel V, Jilg CA, Rischke HC, Beck TI, Schultze-Seemann W, et al. Comparison of 68Ga-HBED-CC PSMA-PET/CT and multiparametric MRI for gross tumour volume detection in patients with primary prostate cancer based on slice by slice comparison with histopathology. Theranostics. 2017;7:228–37. https://doi.org/10.7150/thno.16638.CrossRefPubMedPubMedCentral

10.

Rahbar K, Weckesser M, Huss S, Semjonow A, Breyholz HJ, Schrader AJ, et al. Correlation of intraprostatic tumor extent with 68Ga-PSMA distribution in patients with prostate cancer. J Nucl Med. 2016;57:563–7. https://doi.org/10.2967/jnumed.115.169243.CrossRefPubMed

11.

Eiber M, Weirich G, Holzapfel K, Souvatzoglou M, Haller B, Rauscher I, et al. Simultaneous 68Ga-PSMA HBED-CC PET/MRI improves the localization of primary prostate cancer. Eur Urol. 2016;70:829–36. https://doi.org/10.1016/j.eururo.2015.12.053.CrossRefPubMed

12.

Uprimny C, Kroiss AS, Decristoforo C, Fritz J, von Guggenberg E, Kendler D, et al. (68)Ga-PSMA-11 PET/CT in primary staging of prostate cancer: PSA and Gleason score predict the intensity of tracer accumulation in the primary tumour. Eur J Nucl Med Mol Imaging. 2017;44:941–9. https://doi.org/10.1007/s00259-017-3631-6.CrossRefPubMed

13.

Vargas HA, Akin O, Franiel T, Goldman DA, Udo K, Touijer KA, et al. Normal central zone of the prostate and central zone involvement by prostate cancer: clinical and MR imaging implications. Radiology. 2012;262:894–902. https://doi.org/10.1148/radiol.11110663.CrossRefPubMedPubMedCentral

14.

Sekine T, Barbosa FD, Sah BR, Mader CE, Delso G, Burger IA, et al. PET/MR outperforms PET/CT in suspected occult tumors. Clin Nucl Med. 2017;42:E88–95. https://doi.org/10.1097/Rlu.0000000000001461.CrossRefPubMed

15.

Wollenweber SD, Ambwani S, Delso G, Lonn AHR, Mullick R, Wiesinger F, et al. Evaluation of an atlas-based PET head attenuation correction using PET/CT and MR patient data. IEEE Trans Nucl Sci. 2013;60:3383–90. https://doi.org/10.1109/Tns.2013.2273417.CrossRef

16.

Wollenweber SD, Ambwani S, Lonn AHR, Shanbhag DD, Thiruvenkadam S, Kaushik S, et al. Comparison of 4-class and continuous fat/water methods for whole-body, MR-based PET attenuation correction. IEEE Trans Nucl Sci. 2013;60:3391–8. https://doi.org/10.1109/Tns.2013.2278759.CrossRef

17.

Hricak H, Dooms GC, McNeal JE, Mark AS, Marotti M, Avallone A, et al. MR imaging of the prostate gland: normal anatomy. AJR Am J Roentgenol. 1987;148:51–8. https://doi.org/10.2214/ajr.148.1.51.CrossRefPubMed

18.

Argani P, Walsh PC, Epstein JI. Analysis of the prostatic central zone in patients with unilateral absence of wolffian duct structures: further evidence of the mesodermal origin of the prostatic central zone. J Urol. 1998;160:2126–9.CrossRefPubMed

19.

Leung CS, Srigley JR. Distribution of lipochrome pigment in the prostate gland: biological and diagnostic implications. Hum Pathol. 1995;26:1302–7.CrossRefPubMed

20.

Chen ME, Johnston DA, Tang K, Babaian RJ, Troncoso P. Detailed mapping of prostate carcinoma foci: biopsy strategy implications. Cancer. 2000;89:1800–9.CrossRefPubMed

21.

Mai KT, Belanger EC, Al-Maghrabi HM, Robertson S, Wang D, Margnean C. Primary prostatic central zone adenocarcinoma. Pathol Res Pract. 2008;204:251–8. https://doi.org/10.1016/j.prp.2007.11.002.CrossRefPubMed

22.

Cohen RJ, Shannon BA, Phillips M, Moorin RE, Wheeler TM, Garrett KL. Central zone carcinoma of the prostate gland: a distinct tumor type with poor prognostic features. J Urol. 2008;179:1762–7; discussion 7. https://doi.org/10.1016/j.juro.2008.01.017.CrossRefPubMed

23.

Afshar-Oromieh A, Haberkorn U, Schlemmer HP, Fenchel M, Eder M, Eisenhut M, et al. Comparison of PET/CT and PET/MRI hybrid systems using a 68Ga-labelled PSMA ligand for the diagnosis of recurrent prostate cancer: initial experience. Eur J Nucl Med Mol Imaging. 2014;41:887–97. https://doi.org/10.1007/s00259-013-2660-z.CrossRefPubMed

24.

Lutje S, Blex S, Gomez B, Schaarschmidt BM, Umutlu L, Forsting M, et al. Optimization of acquisition time of 68Ga-PSMA-ligand PET/MRI in patients with local and metastatic prostate cancer. PLoS One. 2016;11:e0164392. https://doi.org/10.1371/journal.pone.0164392.CrossRefPubMedPubMedCentral

25.

Afshar-Oromieh A, Wolf M, Haberkorn U, Kachelriess M, Gnirs R, Kopka K, et al. Effects of arm truncation on the appearance of the halo artifact in (68)Ga-PSMA-11 (HBED-CC) PET/MRI. Eur J Nucl Med Mol Imaging. 2017;44:1636–46. https://doi.org/10.1007/s00259-017-3718-0.CrossRefPubMed

Title: The central zone has increased 68Ga-PSMA-11 uptake: “Mickey Mouse ears” can be hot on 68Ga-PSMA-11 PET
Authors: Daniele A. Pizzuto
Julian Müller
Urs Mühlematter
Niels J. Rupp
Antonia Töpfer
Ashkan Mortezavi
Hannes Nagel
Benedikt Kranzbühler
Daniel Eberli
Irene A. Burger
Publication date: 01-07-2018
Publisher: Springer Berlin Heidelberg
Published in: European Journal of Nuclear Medicine and Molecular Imaging / Issue 8/2018
Print ISSN: 1619-7070
Electronic ISSN: 1619-7089
DOI: https://doi.org/10.1007/s00259-018-3979-2

Keynote webinar | Spotlight on medication adherence

Springer Medicine

The central zone has increased ⁶⁸Ga-PSMA-11 uptake: “Mickey Mouse ears” can be hot on ⁶⁸Ga-PSMA-11 PET

Abstract

Purpose

Methods

Results

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 8/2018

Prognostic role of serial quantitative evaluation of 18F-fluorodeoxyglucose uptake by PET/CT in patients with cardiac sarcoidosis presenting with ventricular tachycardia

Japanese multicenter database of healthy controls for [123I]FP-CIT SPECT

Correction to: 18F-FDG PET in drug-resistant epilepsy due to focal cortical dysplasia type 2: additional value of electroclinical data and coregistration with MRI

Tumor metabolism assessed by FDG-PET/CT and tumor proliferation assessed by genomic grade index to predict response to neoadjuvant chemotherapy in triple negative breast cancer

The impact of a Bayesian penalized-likelihood reconstruction algorithm on delayed-time-point Ga-68-PSMA PET for improved recurrent prostate cancer detection

Parametric mapping using spectral analysis for 11C-PBR28 PET reveals neuroinflammation in mild cognitive impairment subjects